Sarah Pearson
OCTO Trial Management Director
Recent publications
-
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial.
Journal article
Kerr RS. et al, (2016), Lancet oncol, 17, 1543 - 1557
-
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial.
Journal article
Dutton SJ. et al, (2014), Lancet oncol, 15, 894 - 904
-
Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors.
Journal article
Nicum S. et al, (2013), Journal of clinical oncology, 31